Xilio Therapeutics (XLO) Cash & Equivalents (2020 - 2026)
Xilio Therapeutics' Cash & Equivalents came in at $136.04 million for Q2 2026, up 11.9% from $121.55 million a year earlier but down 9.5% from the prior quarter.
Powered by 
Analysis
Xilio Therapeutics (XLO) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Xilio Therapeutics' Cash & Equivalents was $137.53 million, up 148.7% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $55.29 million in FY2024 (+23.7%), $44.7 million in FY2023 (-62.9%), $120.39 million in FY2022 (-39.2%) and $198.05 million in FY2021 (+929.5%).
- The five-year range for quarterly Cash & Equivalents is $33.98 million (Q1 2024) to $198.05 million (Q4 2021).
- Year-over-year, Cash & Equivalents has increased for eight consecutive quarters, with growth averaging 68.7% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2021 (growth of 929.5%), and the weakest in Q1 2024 (a decline of 63.6%).
- Business Quant data shows XLO's Cash & Equivalents at $150.33 million (Q1 2026), $137.53 million (Q4 2025) and $103.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Xilio Therapeutics | 155.82 Mn | -371.85 Mn | - | 136.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.04 Mn |
| Mar 31, 2026 | 150.33 Mn |
| Dec 31, 2025 | 137.53 Mn |
| Sep 30, 2025 | 103.76 Mn |
| Jun 30, 2025 | 121.55 Mn |
| Mar 31, 2025 | 89.07 Mn |
| Dec 31, 2024 | 55.29 Mn |
| Sep 30, 2024 | 61.26 Mn |
| Jun 30, 2024 | 74.95 Mn |
| Mar 31, 2024 | 33.98 Mn |
| Dec 31, 2023 | 44.70 Mn |
| Sep 30, 2023 | 59.77 Mn |
| Jun 30, 2023 | 75.38 Mn |
| Mar 31, 2023 | 93.27 Mn |
| Dec 31, 2022 | 120.39 Mn |
| Sep 30, 2022 | 139.14 Mn |
| Jun 30, 2022 | 159.41 Mn |
| Mar 31, 2022 | 176.96 Mn |
| Dec 31, 2021 | 198.05 Mn |
| Sep 30, 2021 | 99.77 Mn |
API Access
Xilio Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();